retatrutide triple agonist obesity trial 🚨 HOT OFF THE PRESS: Phase 3 data has arrived — and the medicine world is paying attention. In Lilly's TRIUMPH-1 trial, participants receiving the highest dose achieved an average retatrutide triple agonist phase 2

Adding less water (e.g., 1 mL) creates a higher concentration, meaning smaller volume (fewer units) is needed per dose

It does not cause gastrointestinal symptoms

You think youre large for your whole life and you look [back] and youre like, 'I was fit.' Yeah, I had big muscles

Matthew R Hayes, Heath D Schmidt, GLP-1 influences food and drug reward, Current Opinion in Behavioral Sciences, Volume 9, 2016, Pages 66-70, ISSN 2352-1546 Hjerpsted JB, Flint A, Brooks A, Axelsen MB, Kvist T, Blundell J

People with diabetes need extra caution because medicines that affect appetite, digestion, and glucose regulation can change blood sugar patterns

Research teams building out a broader metabolic research panel alongside GLP-3 RT often reference our guide to peptides for fat loss researchwhen scoping protocol size